Results 111 to 120 of about 111,529 (192)

LDL apheresis or PCSK9 inhibition? Sometimes we have to combine them

, 2017
This study presents the case of a female patient with severe heterozygous familial hypercholesterolemia. Despite the combined maximum dose oral treatment with rosuvastatin and ezetimibe, we found markedly elevated lipid parameters.
Nádró, Bíborka, Juhász, Lilla, Paragh, György, Harangi, Mariann, Balla, József   +4 more
core  

Clinical considerations on the use of evinacumab for the treatment of homozygous familial hypercholesterolemia. [PDF]

Am J Prev Cardiol
Bajaj A, McGuire M, Shugg S, Godin R, Underberg JA.   +4 more
europepmc   +1 more source

Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia. [PDF]

Lipids Health Dis, 2016
Varga VE, Lőrincz H, Zsíros N, Fülöp P, Seres I, Paragh G, Balla J, Harangi M.   +7 more
europepmc   +1 more source

Public availability of trial-design and clinical-context information in contemporary lipoprotein(a)-targeted cardiovascular trials: A cross-sectional meta-research study. [PDF]

Am Heart J Plus
Tan S, Gu J, Yow D, Zheng L.
europepmc   +1 more source

The Impact of Lipoprotein apheresis on Plasma Protein Levels: A Meta-Analysis. [PDF]

J Clin Apher
Aslani S, Eslami M, Hatami A, Alizadeh S, Razi B, Almahmeed W, Jamialahmadi T, Sahebkar A.   +7 more
europepmc   +1 more source

Familial Hypercholesterolemia. [PDF]

Methodist Debakey Cardiovasc J
Iatan I, Genest J.
europepmc   +1 more source

Treatment patterns in homozygous familial hypercholesterolemia: Undertreatment and delayed adoption of low-density lipoprotein receptor-independent therapies. [PDF]

Am J Prev Cardiol
Murdock DJ, Wang L, Gu J, Sanchez RJ, Godin R, Brandt EJ.   +5 more
europepmc   +1 more source

The effect of DALI lipid apheresis in the prognosis of homozygous familial hypercholesterolemia: Seven patients' experience at a DALI apheresis center

Annals of Pediatric Cardiology, 2020
Muhammet Bulut, Kemal Nisli, Aygün Dindar   +2 more
doaj   +1 more source

Is FH a curable disease? [PDF]

Glob Cardiol Sci Pract
Seidah NG.
europepmc   +1 more source

Lipoprotein(a) in Personalized Cardiovascular Prevention: Risk Stratification, Coronary Artery Calcium, and Emerging Lp(a)-Lowering Therapies. [PDF]

J Clin Med
Syed AB, Michalak S, Potulapati IKR, Vignarajah A, Shah GV.   +4 more
europepmc   +1 more source